Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

L.B. Foster Sees FY2024 Sales $525.000M-560.000M vs $548.89M Est

Author: Benzinga Newsdesk | May 07, 2024 08:03am

Financial Guidance

2024 Full Year Financial Guidance	Low			High
Net sales	$	525,000	$	560,000
Adjusted EBITDA	$	34,000	$	39,000
Free cash flow	$	12,000	$	18,000
Capital spending as a percent of sales	2.0	%	2.5	%

Posted In: FSTR

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Biogen Inc. (BIIB)